For drug manufacturers and pharmaceutical companies, patient recruitment is the "elephant in the room". It is the primary cause of missing deadlines and early termination for a clinical trial if the trial fails to meet recruitment goals. Dealing with delays can be expensive, on top of already expensive clinical trial costs. As of 2015, just to develop and gain approval of one new prescription drug would cost a pharmaceutical company upwards of $2 billion dollars. 

Here are 3 steps to developing a successful patient recruitment strategy. 

Read More...